GGrantIndex
Sort

130,381 grants matching hiv

Pandemic Preparedness: Biocontainment Facility Upgrade and Integration at UTMB/Galveston National Laboratory

$7,131,815
Gary Kobinger · University Of Texas Med Br Galveston · G20 · FY2022 · AI

HIV Testing and Counseling in STD Clinics: an Adaptation of CTN 0032

$7,123,365
Lisa R Metsch · University Of Miami School Of Medicine · RC2 · FY2009 · DA

GENERAL CLINICAL RESEARCH CENTER

$7,120,143
Richard D Krugman · University Of Colorado Denver · M01 · FY2006 · RR

Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network

$7,116,100
Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2008 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$7,115,040
Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U62 · FY2012 · PS

HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA

$7,111,676
Craig R Cohen · University Of California, San Francisco · U62 · FY2008 · PS

Units for HIV/AIDS Clinical Trials Networks

$7,098,824
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2011 · AI

The Infectious Diseases Clinical Research Program (IDCRP)

$7,098,800
National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI

Martin Delaney Collaboratory to Eradicate HIV-1 Infection

$7,096,518
David M. Margolis · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI

NIAID VRC NUCLEIC ACID AND LIPID TECHNOLOGY DEVELOPMENT

$7,090,787
Victoria Coleman · Leidos Biomedical Research, Inc. · N01 · FY2023 · AI

PS08-871, S. Africa: CATHOLIC CHURCH RESPONSE TO HIV AND AIDS IN SOUTH AFRICA: CARE, SUPPORT AND TREAT

$7,083,230
Alison Munro · Southern African Catholic Bishops Conf · U2G · FY2012 · PS

South Africa MRC HIV Prevention Trials Unit

$7,068,878
Gita Ramjee · Medical Research Council Of South Africa · U01 · FY2010 · AI

Production of a Broadly Neutralizing HIV Antibody (VRC01)

$7,055,396
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI

Production of a Broadly Neutralizing HIV Antibodies

$7,055,396
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2013 · AI

Production of a Broadly Neutralizing HIV Antibodies

$7,055,396
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI

HIV PREVENTION, TREATMENT, AND CARE CAPACITY BUILDING FOR LOCAL ORGANIZATIONS

$7,034,435
William C Philbrick · Care Usa · U62 · FY2008 · PS

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$7,030,860
Deborah B. McGruder · Maryland State Department Of Health · U62 · FY2013 · PS

Pandemic preparedness research and biocontainment infrastructure at The Rockefeller University

$7,019,416
Timothy O'Connor · Rockefeller University · G20 · FY2022 · AI

Consortium for AIDS Vaccine Research in Nonhuman Primates

$7,013,564
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI

XIX International AIDS Conference (AIDS 2012)

$7,010,000
Chris Beyrer · Ias · R13 · FY2011 · AI

Advanced Non Invasive Vascular Imaging Methods

$7,009,057
Ahmed Gharib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern

$7,007,011
Judith S. Currier · University Of California Los Angeles · UM1 · FY2022 · AI

AVANTE ZAMBZIA: TECHNICAL ASSISTANCE TO THE MINISTRY OF HEALTH (MOH) FOR HIV SERV

$7,004,599
C. William Wester · Vanderbilt University · U2G · FY2012 · GH

PROVISION OF MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL

$7,000,000
Scott Billy · Population Services International · U2G · FY2011 · GH

Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)

$6,995,851
Diane V Havlir · University Of California, San Francisco · U01 · FY2014 · AI